Eteplirsen is a medication that has been developed for the treatment of Duchenne muscular dystrophy (DMD), a severe type of muscular dystrophy that primarily affects boys. It is an antisense oligonucleotide that targets exon 51 of the dystrophin gene, promoting exon skipping to produce a truncated but functional form of the dystrophin protein.
